Utilizing proximity-based amplification technology, the assay combines the analyte specificity of high-affinity antibody-antigen binding with the signal detection and amplification capabilities of real-time PCR to achieve a simple yet powerful…
Utilizing proximity-based amplification technology, the assay combines the analyte specificity of high-affinity antibody-antigen binding with the signal detection and amplification capabilities of real-time PCR to achieve a simple yet powerful next-generation protein quantitation platform. A user-friendly workflow combined with intuitive software for analytics enables sample-to-answer in just 2 hours.
Type I interferons (IFN-alpha/beta) are produced primarily in response to viral infection by natural IFN producing cells (IPC) as part of the host's immune response. The development of tumours can also be inhibited by L-IFNS. IFN-beta bonding results in the activation of tyrosine kinases Jak1 and Tyk2, the phosphorylation of transcription factors in STAT family members, and the transcription and expression of immune response genes. More recently, several members of the toll receiver family (TLR) have been found to stimulate IFN-beta production. The IFN-beta is currently used clinically for the treatment of tumours, infections and multiple sclerosis.
High sensitivity-detect low levels of protein…
High sensitivity-detect low levels of protein with greater sensitivity than traditional methods
Broad dynamic range-5 logarithmic units...
Broad dynamic range-5 logarithmic units, minimizing sample dilutions to ensure they fall within the range
Small sample consumption-use 2–5 μL of sample…
Small sample consumption-use 2–5 μL of sample (compared to 75 μL for triplicate wells with other methods)
Fast, easy workflow-2 hours from sample to…
Fast, easy workflow-2 hours from sample to answer, with no wash steps
No proprietary instrument to purchase-runs on any…
No proprietary instrument to purchase-runs on any real-time PCR instrument
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17114313 |
| Specifications |
| Accession number | Fibroblast interferon; IFB; IFF; IFN b; IFN ß; IFNB; IFNB1; IFNbeta; IFN-beta; IFNß; Interferon b; interferon beta; interferon beta 1; interferon beta 1, fibroblast; Interferon beta protein; interferon beta 1; interferon beta 1, Fibroblast; interferon beta; RP11-113D19.1 |
| Dose range | 0.32 to 5.000 pg/ml |
| Sensitivity of the dosage | <0.3 pg/ml |
| Product type | ELISA |
| Genetic identification (Enter) | P01575 |
| Gene symbol(s) | Ifnb1 |
| Contents of kits | Antibody-Conjugate Antibody-Conjugate B Test Dilution Stamp Antibody-Conjugate Standard Master Mix ligase |
| Quantity | 96 tests |
| Regulatory status | Use exclusively for research |
| Target | IFN beta |
| Test time | 30 min |
| Physical characteristics |
| Volume of sample | Serum, 2-5 µl; plasma, 2-5 µl; supernatant, 2-5 µl |
| Storage and shipping |
| Storage conditions | -20°C |
| Total duration of dosing | 2 h |
Origin and customs
| Manufacturer ref. | A47435 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 12 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.